You are here

  • Home
  • Archive
  • Volume 5, Issue 1
  • Whole-blood RNA transcript-based models can predict clinical response in two large independent clinical studies of patients with advanced melanoma treated with the checkpoint inhibitor, tremelimumab

Article metrics

Article menu

Download PDFPDF

XML
Research Article
Whole-blood RNA transcript-based models can predict clinical response in two large independent clinical studies of patients with advanced melanoma treated with the checkpoint inhibitor, tremelimumab

 

Online download statistics by month:

Online download statistics by month: December 2019 to May 2022

AbstractFullPdf
Dec 2019220
Jan 2020552
Feb 202010101
Mar 202017172
Apr 2020882
May 202020204
Jun 202017173
Jul 202010102
Aug 2020991
Sep 202019190
Oct 202021212
Nov 202017171
Dec 202012124
Jan 2021652
Feb 202118185
Mar 202112127
Apr 202114143
May 202111116
Jun 202120201
Jul 202116167
Aug 202126265
Sep 202118181
Oct 202118188
Nov 202110105
Dec 202122228
Jan 2022303410
Feb 202225299
Mar 202235387
Apr 202221235
May 2022353611
Total504517124